Obstructive sleep apnea as a risk factor for cardiovascular diseases

dc.authorid0000-0002-9205-5708
dc.authorid0000-0003-0582-8723
dc.authorid0000-0003-2541-4675
dc.contributor.authorYılmaz, Fahrettin
dc.contributor.authorÖzyıldırım, Serhan
dc.contributor.authorTalay, Fahrettin
dc.contributor.authorKaraaslan, Kazım
dc.contributor.authorGündüz, Hüseyin
dc.date.accessioned2021-06-23T18:54:08Z
dc.date.available2021-06-23T18:54:08Z
dc.date.issued2007
dc.departmentBAİBÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.description.abstractObstructive sleep apnea (OSA) is a common medical condition that occurs in approximately 5% to 15% of the population. It is usually associated with an increased risk of cardiovascular disease. Diagnosis of OSA is based on polysomnography, and its severity is measured with an apnea-hypopnea index. Most of the adverse effects of OSA on the cardiovascular system are reversible with treatment. In addition to continous positive airway pressure therapy, precautions such as weight loss, avoidance of central nervous system depressants, treatment of nasal congestion and sleeping in the lateral position may help to treat OSA. Copyright © 2007 Via Medica.en_US
dc.identifier.endpage537en_US
dc.identifier.issn1897-5593
dc.identifier.issue6en_US
dc.identifier.scopus2-s2.0-39549111220en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage534en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12491/4248
dc.identifier.volume14en_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorKaraaslan, Kazım
dc.language.isoenen_US
dc.relation.ispartofCardiology Journalen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCardiovascular systemen_US
dc.subjectObstructive sleep apneaen_US
dc.titleObstructive sleep apnea as a risk factor for cardiovascular diseasesen_US
dc.typeReview Articleen_US

Dosyalar